Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Next Generation Antibody Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Next Generation Antibody Therapeuticsmarket, defines the market attractiveness level of Next Generation Antibody Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Next Generation Antibody Therapeutics industry, describes the types of Next Generation Antibody Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Next Generation Antibody Therapeutics market and the development prospects and opportunities of Next Generation Antibody Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Next Generation Antibody Therapeutics market in Chapter 13.
By Player:
Roche
Bristol-Myers Squibb
Biogen
Kyowa Hakko Kirin
Pfizer
Bayer
Seattle Genetics
Takeda Pharmaceuticals
ImmunoGen
AstraZeneca
Xencor
Amgen
Dyax Corp
By Type:
Antibody Drug Conjugates (ADCs)
Bispecific Antibodies (BsAbs)
Fc Engineered Antibodies
Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Biosimilar Antibody (Ab) Products
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Next Generation Antibody Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Next Generation Antibody Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Next Generation Antibody Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Next Generation Antibody Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Next Generation Antibody Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.2 United States Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.3 Europe Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.4 China Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.5 Japan Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.6 India Next Generation Antibody Therapeutics Consumption (2017-2022)
-
7.7 South Korea Next Generation Antibody Therapeutics Consumption (2017-2022)
8 Region and Country-wise Next Generation Antibody Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Next Generation Antibody Therapeutics Consumption Forecast (2022-2028)
9 Global Next Generation Antibody Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Next Generation Antibody Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibody Drug Conjugates (ADCs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bispecific Antibodies (BsAbs) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fc Engineered Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Biosimilar Antibody (Ab) Products Consumption and Growth Rate (2017-2022)
-
9.2 Global Next Generation Antibody Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Next Generation Antibody Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibody Drug Conjugates (ADCs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bispecific Antibodies (BsAbs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fc Engineered Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Biosimilar Antibody (Ab) Products Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Next Generation Antibody Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Next Generation Antibody Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Next Generation Antibody Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Next Generation Antibody Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Next Generation Antibody Therapeutics Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Next Generation Antibody Therapeutics Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Next Generation Antibody Therapeutics Product and Service
-
14.3 Biogen
-
14.3.1 Biogen Company Details
-
14.3.2 Biogen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biogen Next Generation Antibody Therapeutics Product and Service
-
14.4 Kyowa Hakko Kirin
-
14.4.1 Kyowa Hakko Kirin Company Details
-
14.4.2 Kyowa Hakko Kirin Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kyowa Hakko Kirin Next Generation Antibody Therapeutics Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Next Generation Antibody Therapeutics Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Next Generation Antibody Therapeutics Product and Service
-
14.7 Seattle Genetics
-
14.7.1 Seattle Genetics Company Details
-
14.7.2 Seattle Genetics Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Seattle Genetics Next Generation Antibody Therapeutics Product and Service
-
14.8 Takeda Pharmaceuticals
-
14.8.1 Takeda Pharmaceuticals Company Details
-
14.8.2 Takeda Pharmaceuticals Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Takeda Pharmaceuticals Next Generation Antibody Therapeutics Product and Service
-
14.9 ImmunoGen
-
14.9.1 ImmunoGen Company Details
-
14.9.2 ImmunoGen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 ImmunoGen Next Generation Antibody Therapeutics Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Next Generation Antibody Therapeutics Product and Service
-
14.11 Xencor
-
14.11.1 Xencor Company Details
-
14.11.2 Xencor Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Xencor Next Generation Antibody Therapeutics Product and Service
-
14.12 Amgen
-
14.12.1 Amgen Company Details
-
14.12.2 Amgen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Amgen Next Generation Antibody Therapeutics Product and Service
-
14.13 Dyax Corp
-
14.13.1 Dyax Corp Company Details
-
14.13.2 Dyax Corp Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Dyax Corp Next Generation Antibody Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Next Generation Antibody Therapeutics
-
Figure Next Generation Antibody Therapeutics Picture
-
Table Global Next Generation Antibody Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Antibody Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Next Generation Antibody Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Next Generation Antibody Therapeutics Consumption by Country (2017-2022)
-
Figure United States Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Next Generation Antibody Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Next Generation Antibody Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Next Generation Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody Drug Conjugates (ADCs) Consumption and Growth Rate (2017-2022)
-
Figure Global Bispecific Antibodies (BsAbs) Consumption and Growth Rate (2017-2022)
-
Figure Global Fc Engineered Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Consumption and Growth Rate (2017-2022)
-
Figure Global Biosimilar Antibody (Ab) Products Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugates (ADCs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bispecific Antibodies (BsAbs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fc Engineered Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biosimilar Antibody (Ab) Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Next Generation Antibody Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Next Generation Antibody Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Next Generation Antibody Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Next Generation Antibody Therapeutics Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Next Generation Antibody Therapeutics Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Next Generation Antibody Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Next Generation Antibody Therapeutics Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Next Generation Antibody Therapeutics Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Next Generation Antibody Therapeutics Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Next Generation Antibody Therapeutics Product and Service
-
Table ImmunoGen (Foundation Year, Company Profile and etc.)
-
Table ImmunoGen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoGen Next Generation Antibody Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Next Generation Antibody Therapeutics Product and Service
-
Table Xencor (Foundation Year, Company Profile and etc.)
-
Table Xencor Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xencor Next Generation Antibody Therapeutics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Next Generation Antibody Therapeutics Product and Service
-
Table Dyax Corp (Foundation Year, Company Profile and etc.)
-
Table Dyax Corp Next Generation Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dyax Corp Next Generation Antibody Therapeutics Product and Service
-
